5-6600087-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_017755.6(NSUN2):​c.2143G>A​(p.Val715Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00793 in 1,614,208 control chromosomes in the GnomAD database, including 68 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V715F) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0056 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0082 ( 64 hom. )

Consequence

NSUN2
NM_017755.6 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: -0.188

Publications

11 publications found
Variant links:
Genes affected
NSUN2 (HGNC:25994): (NOP2/Sun RNA methyltransferase 2) This gene encodes a methyltransferase that catalyzes the methylation of cytosine to 5-methylcytosine (m5C) at position 34 of intron-containing tRNA(Leu)(CAA) precursors. This modification is necessary to stabilize the anticodon-codon pairing and correctly translate the mRNA. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Mar 2011]
LINC01018 (HGNC:27394): (long intergenic non-protein coding RNA 1018)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031422377).
BP6
Variant 5-6600087-C-T is Benign according to our data. Variant chr5-6600087-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211757.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00557 (849/152324) while in subpopulation NFE AF = 0.00966 (657/68030). AF 95% confidence interval is 0.00905. There are 4 homozygotes in GnomAd4. There are 385 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NSUN2NM_017755.6 linkc.2143G>A p.Val715Ile missense_variant Exon 19 of 19 ENST00000264670.11 NP_060225.4 Q08J23-1
NSUN2NM_001193455.2 linkc.2038G>A p.Val680Ile missense_variant Exon 18 of 18 NP_001180384.1 Q08J23-2
NSUN2NR_037947.2 linkn.2123G>A non_coding_transcript_exon_variant Exon 18 of 18

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NSUN2ENST00000264670.11 linkc.2143G>A p.Val715Ile missense_variant Exon 19 of 19 1 NM_017755.6 ENSP00000264670.6 Q08J23-1

Frequencies

GnomAD3 genomes
AF:
0.00557
AC:
848
AN:
152206
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00205
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00478
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00964
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00515
AC:
1295
AN:
251492
AF XY:
0.00534
show subpopulations
Gnomad AFR exome
AF:
0.00160
Gnomad AMR exome
AF:
0.00344
Gnomad ASJ exome
AF:
0.00337
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00111
Gnomad NFE exome
AF:
0.00908
Gnomad OTH exome
AF:
0.00537
GnomAD4 exome
AF:
0.00817
AC:
11948
AN:
1461884
Hom.:
64
Cov.:
32
AF XY:
0.00805
AC XY:
5854
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.00137
AC:
46
AN:
33480
American (AMR)
AF:
0.00326
AC:
146
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00386
AC:
101
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00130
AC:
112
AN:
86258
European-Finnish (FIN)
AF:
0.00135
AC:
72
AN:
53418
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5768
European-Non Finnish (NFE)
AF:
0.00998
AC:
11099
AN:
1112004
Other (OTH)
AF:
0.00601
AC:
363
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
660
1321
1981
2642
3302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
426
852
1278
1704
2130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00557
AC:
849
AN:
152324
Hom.:
4
Cov.:
33
AF XY:
0.00517
AC XY:
385
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00204
AC:
85
AN:
41576
American (AMR)
AF:
0.00477
AC:
73
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00966
AC:
657
AN:
68030
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
46
92
137
183
229
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00813
Hom.:
10
Bravo
AF:
0.00584
TwinsUK
AF:
0.00998
AC:
37
ALSPAC
AF:
0.0106
AC:
41
ESP6500AA
AF:
0.00272
AC:
12
ESP6500EA
AF:
0.00744
AC:
64
ExAC
AF:
0.00506
AC:
614
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00862
EpiControl
AF:
0.00889

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:5
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 17, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 01, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NSUN2: BP4, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Intellectual disability Uncertain:1
Mar 27, 2020
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 06, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 02, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Intellectual disability, autosomal recessive 5 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
1.0
DANN
Benign
0.50
DEOGEN2
Benign
0.058
T;.
Eigen
Benign
-0.96
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.71
T;T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.0031
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L;.
PhyloP100
-0.19
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.31
N;N
REVEL
Benign
0.011
Sift
Benign
0.28
T;T
Sift4G
Benign
0.43
T;T
Polyphen
0.094
B;.
Vest4
0.041
MVP
0.27
MPC
0.045
ClinPred
0.00060
T
GERP RS
0.24
Varity_R
0.017
gMVP
0.16
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112951498; hg19: chr5-6600200; COSMIC: COSV99072667; COSMIC: COSV99072667; API